Pathogenic variants in SDHB in PPGL patients are associated with a higher risk of tumor progression, and several studies have shown that SDHB pathogenic variation can be detected by the loss of SDHB staining in immunohistochemistry (IHC). This evidence concerns the gene SDHB and neoplasm.